|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Role ofthe JAK/STAT Signal Transduetion Pathway in the Regulation of Gene Expression in CNS显示文摘 | Santangelo R Torrisi L | 2003 | Neurochem Res2003，28，1： | 1 |
| 2 | Tailored preoperative treatment of locally advanced triple negative ( hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel 显示文摘 | Torrisi R Balduzzi A Ghisini R | 2008 | Cancer Chemother Pharmacol2008，62，4： | 1 |
| 3 | The phospholipid composition of extracellular herpes simplex virions differs from that of host cell nuclei显示文摘 | van Genderen I L Brandimarti R Torrisi M R | 1994 | Virology1994，200，： | 1 |
| 4 | Antitumour and biological effects of Letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancer显示文摘 | Torrisi R Bagnardi V Pruneri G | 2007 | Br J Cancer2007，97，6： | 1 |
| 5 | Trastuzumab-induced cardiotoxicity:clinical and prognostic implications of troponin Ⅰ evaluation显示文摘 | Cardinale D Colombo A Torrisi R | 2010 | J Clin Oncol2010，28，25： | 1 |
| 6 | A natural antisense transcript against Rad1 8,specifically expressed in neurons and upregulated during beta-amyloid-induced apoptosis显示文摘 | Parenti R Paratore S Torrisi A | | 0，，09： | 1 |
| 7 | Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, eisplatin, and infusional fluorouracil followed by weekly paclitaxe显示文摘 | Torrisi R Balduzzi A Ghisini R | 2008 | Cancer Chemother Pharmacol2008，62，： | 1 |
| 8 | Tailored preoperative treatment of locally advanced triple negative(hormone receptor negative and HER2negative)breast cancer with epirubicin,cisplatin,and infusional fluorouracil followed by weekly paclitaxel显示文摘 | Torrisi R Balduzzi A Ghisini R Rocca A Bottiglieri L Giovanardi F | 2008 | Cancer Chemother Pharmacol2008，62，4： | 1 |
| 9 | Tailored preoperative treat- ment of locally advanced triple negative( hormone receptor negative and HER2 negative) breast cancer with epirubicin, eieplatin, and infusional fluorouracil followed by weekly paclitaxel 显示文摘 | Torrisi R Balduzzi A Ghisini R | 2008 | Cancer Chemother Pharmaeol2008，62，4： | 1 |
| 10 | Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancer 显示文摘 | Torrisi R Bagnardi V Rotmensz N | 2011 | Breast Cancer Res Treat2011，126，2： | 1 |
| 11 | Tm-doped fi- ber laser mode-locked by graphene-polymer composite 显示文摘 | Zhang M Kelleher E J R Torrisi F | 2012 | Optics Express2012，20，25： | 1 |
| 12 | Receptors for thymosin alpha 1 on mouse thymocytes显示文摘 | RINALDI G C TORRISI M R JEZZI T | 1985 | Cell Immunol1985，91，1： | 1 |
| 13 | Extratesticular Leydig cell tumor of the spermatic cord显示文摘 | Lanzafame S Leonardi R Torrisi A | 2004 | J Urol2004，171，3： | 1 |
| 14 | Recombinant human growthhormone: old and novel uses显示文摘 | Tritos NA Mantaoros CS Torrisi R | 1998 | Am J Med1998，105，： | 1 |
| 15 | Extratesticular Leydig cell tumor of the spermatic cord 显示文摘 | LANZAFAME S LEONARDI R TORRISI A | 2004 | J Urol2004，171，3： | 1 |
| 16 | Tailored preoperative treat- ment of locally advanced triple negative ( hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel 显示文摘 | Torrisi R Balduzzi A Ghisini R | 2008 | Cancer Chemother Pharmacol2008，62，4： | 1 |
| 17 | Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER-2 negative) breast cancer with epirubicin,cisplatin,andinfusional fluorouracil followed by weekly paclitaxel显示文摘 | Torrisi R Balduzzi A Ghisini R | 2008 | Cancer Chemother Pharmacol2008，62，4： | 1 |
| 18 | HER2 status in early breast cancer:relevance of cell staining patterns,gene amplification and polysomy 17显示文摘 | Torrisi R Rotmensz N Baqnardi V | | 0，，16： | 1 |
| 19 | Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel显示文摘 | Torrisi R Balduzzi A Ghisini R | 2008 | Cancer Chemother Pharmacol2008，62，4： | 1 |
| 20 | Tailored preoperative treatment of locally advanced triple negative breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel 显示文摘 | Torrisi R Balduzzi A Ghisini R | 2008 | Cancer Chemother Pharmacol2008，62，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员